Your browser doesn't support javascript.
loading
Improved durable pulmonary vein isolation with shorter procedure times and lower energy levels using RF ablation with ablation index and a stringent lesion contiguity.
Theis, Cathrin; Huber, Carola; Kaiser, Bastian; Kaesemann, Philipp; Hui, Felix; Pirozzolo, Giancarlo; Bekeredjian, Raffi.
Afiliação
  • Theis C; Department of Cardiology, Robert Bosch Hospital Stuttgart, Germany. Electronic address: cathrin.theis@rbk.de.
  • Huber C; Department of Cardiology, Robert Bosch Hospital Stuttgart, Germany.
  • Kaiser B; Department of Cardiology, Robert Bosch Hospital Stuttgart, Germany.
  • Kaesemann P; Department of Cardiology, Robert Bosch Hospital Stuttgart, Germany.
  • Hui F; Department of Cardiology, Robert Bosch Hospital Stuttgart, Germany.
  • Pirozzolo G; Department of Cardiology, Robert Bosch Hospital Stuttgart, Germany.
  • Bekeredjian R; Department of Cardiology, Robert Bosch Hospital Stuttgart, Germany.
Indian Pacing Electrophysiol J ; 21(6): 337-341, 2021.
Article em En | MEDLINE | ID: mdl-34438060
BACKGROUND: The single procedure success rates of durable pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) varies between 80 and 90%. Ablation index, incorporating contact force, stability, time and power is a more profound parameter of significant lesion size and has been established. Equally important is a stringent contiguity of the lesion set. METHODS AND RESULTS: A total number of 100 consecutive patients undergoing de-novo catheter ablation for paroxysmal atrial fibrillation (PAF) were analyzed between 2016 and 2019. In the first 50 patients (group A) PVI was performed using a surround flow, contact force catheter (Biosense Webster Thermocool STSF, Biosense Webster, USA) with a drag-and-ablate technique to encircle the PVs. In the following 50 patients (group B), PVI was performed using ablation index and a stringent lesion contiguity with an interlesion distance (ILD) of <5 mm. The baseline characteristics showed no significant differences between both groups. During a mean follow-up of 18 ± 3 months after a single procedure, 36 (72%) patients of group A were free of arrhythmia recurrence versus 43 (86%) patients in group B (p = 0.047). A total of 14 patients (group A: 10 (20%), group B: 4 (8%); underwent a redo-procedure. 7 patients of group A (14%) and 2 patients of group B (4%) showed recovered veins. In 3 patients of group A and 2 patients of group B the PVs were durably isolated. In these patients persistent AF recurrence was caused by extra-PV AF sources. Four patients of group A and three patients of group B had continued paroxysmal or persistent AF but did not undergo redo-procedure. With regard to the procedural data, the procedure time, the total energy and the fluoroscopy time were significantly lower in group B (AI and ILD <5 mm) (128.86 ± 18.19 versus 115.35 ± 15.38; p < 0.05; 1619.16 ± 988.56 versus 1186.26 ± 756.34; p < 0.05; 11.49 ± 3.20 versus 9.66 ± 3.86; p = 0.04). Both procedures were performed with a low number of complications, no pericardial effusion was seen in either group. CONCLUSIONS: PVI using ablation index in combination with a stringent lesion contiguity improves clinical outcome after first-time PVI with lower PVI recovery, shorter procedure times, lower total energy and shorter fluoroscopy times and therefore, is more efficient.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Indian Pacing Electrophysiol J Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Indian Pacing Electrophysiol J Ano de publicação: 2021 Tipo de documento: Article